98%
921
2 minutes
20
Preterm Premature Rupture of Membrane (PPROM) constitutes a prevalent obstetric complication that markedly heightens the risk of neonatal mortality and low birth weight, while also potentially impacting the psychological well-being of the mother. Despite established associations between PPROM and various underlying medical conditions or lifestyle factor, a definitive treatment strategy continues to remain unattainable. Contemporary research indicates that dysbiosis of the gut microbiome may play a significant role in the pathogenesis of PPROM. Consequently, this study endeavors to gather recent findings related to the mechanisms underlying intestinal dysbiosis in relation to PPROM. It aims to offer novel insights into this critical issue. An increasing amount of evidence suggests that specific intestinal bacteria have the capacity to translocate into the vascular system and the amniotic cavity during pregnancy. This happens as a consequence of imbalances or dysbiosis within the gut microbiota. This translocation may be facilitated by the presence of bacteria within the amniotic cavity, modifications in the vaginal microbiota, and activation of the Hypothalamus-Pituitary-Adrenal (HPA) axis, which initiates a physiological cascade that accelerates the progression of PPROM. In light of these findings, the preservation of gut microbial homeostasis, particularly through the application of probiotics or dietary modifications, may serve to alleviate the detrimental effects of dysbiosis on PPROM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.micpath.2025.107673 | DOI Listing |
Brain Behav
September 2025
Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Introduction: Anxiety and stress are prevalent mental health issues. Traditional drug treatments often come with unwanted side effects and may not produce the desired results. As an alternative, probiotics are being used as a treatment option due to their lack of specific side effects.
View Article and Find Full Text PDFChin Med J (Engl)
September 2025
Medical Center of Hematology, Xinqiao Hospital, Army Military Medical University, Chongqing 400037, China.
Folia Microbiol (Praha)
September 2025
Department of Gastroenterology, Chongqing University Cancer Hospital, Chongqing, China.
Microbiome dysbiosis in reflux esophagitis has been extensively studied. However, limited research has examined microbiota across different segments of the upper gastrointestinal tract in reflux esophagitis. In this study, we investigated microbial alterations in three esophageal segments (upper, middle, and lower) and the gastric fundus of reflux esophagitis patients and healthy controls.
View Article and Find Full Text PDFNat Cancer
September 2025
Nature Cancer, .
J Immunother Cancer
September 2025
National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Background: Improving the efficacy of anti-programmed death 1 (PD-1) monoclonal antibody (mAb) therapy remains a major challenge for cancer immunotherapy in non-small cell lung cancer (NSCLC). Gut microbial metabolites can influence immunotherapy efficacy.
Methods: ELISA was used to compare the serum 5-hydroxyindoleacetic acid (5-HIAA) level in patients with NSCLC.